Astrana Health Price to Book Ratio 2016-2026 | ASTH
Historical price to book ratio values for Astrana Health (ASTH) over the last 10 years. The current price to book ratio for Astrana Health as of September 15, 2026 is 2.54.
| Astrana Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 37.70 | 2.21 | |
| 2026-06-30 | 46.41 | $17.08 | 2.72 |
| 2026-03-31 | 24.52 | $16.66 | 1.47 |
| 2025-12-31 | 24.81 | $16.23 | 1.53 |
| 2025-09-30 | 28.35 | $15.98 | 1.77 |
| 2025-06-30 | 24.88 | $15.70 | 1.58 |
| 2025-03-31 | 31.01 | $15.31 | 2.03 |
| 2024-12-31 | 31.53 | $14.95 | 2.11 |
| 2024-09-30 | 57.94 | $14.85 | 3.90 |
| 2024-06-30 | 40.56 | $14.37 | 2.82 |
| 2024-03-31 | 41.99 | $13.86 | 3.03 |
| 2023-12-31 | 38.30 | $13.16 | 2.91 |
| 2023-09-30 | 30.85 | $12.82 | 2.41 |
| 2023-06-30 | 31.60 | $12.24 | 2.58 |
| 2023-03-31 | 36.47 | $11.85 | 3.08 |
| 2022-12-31 | 29.59 | $11.69 | 2.53 |
| 2022-09-30 | 39.00 | $11.44 | 3.41 |
| 2022-06-30 | 38.59 | $10.86 | 3.55 |
| 2022-03-31 | 48.47 | $10.69 | 4.53 |
| 2021-12-31 | 73.48 | $10.17 | 7.22 |
| 2021-09-30 | 91.05 | $9.92 | 9.18 |
| 2021-06-30 | 62.81 | $9.14 | 6.87 |
| 2021-03-31 | 27.09 | $8.20 | 3.30 |
| 2020-12-31 | 18.27 | $7.82 | 2.34 |
| 2020-09-30 | 17.94 | $6.24 | 2.88 |
| 2020-06-30 | 16.50 | $5.72 | 2.88 |
| 2020-03-31 | 12.92 | $5.49 | 2.35 |
| 2019-12-31 | 18.41 | $5.36 | 3.44 |
| 2019-09-30 | 17.62 | $5.52 | 3.19 |
| 2019-06-30 | 16.71 | $5.37 | 3.11 |
| 2019-03-31 | 18.32 | $5.29 | 3.47 |
| 2018-12-31 | 19.85 | $5.25 | 3.78 |
| 2018-09-30 | 22.07 | $5.61 | 3.94 |
| 2018-06-30 | 25.86 | $5.32 | 4.86 |
| 2018-03-31 | 15.95 | $5.22 | 3.05 |
| 2017-12-31 | 24.00 | $5.08 | 4.72 |
| 2017-09-30 | 9.75 | 0.00 | |
| 2017-06-30 | 10.00 | 0.00 | |
| 2017-03-31 | 9.00 | 0.00 | |
| 2016-12-31 | 7.50 | 0.00 | |
| 2016-03-31 | 5.93 | 0.00 | |
| 2015-03-31 | 5.00 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |